News

We invite you to visit our news section for updates on research articles related
to maternal and neonatal mortality and technology, MANDATE in the news, and information
on new technology briefs.

FEB

1

Lancet series on ending preventable stillbirths

The Lancet Ending preventable stillbirth Series was recently released and reports the present state of stillbirths, highlights missed opportunities, and identifies actions for accelerated progress to end preventable stillbirths and reach 2030 maternal, neonatal, and child survival targets.

Pre-eclampsia as underlying cause of perinatal death

Hodgins recently published a call to action for preventing perinatal deaths due to preeclampsia/eclampsia.
The full editorial can be read here: http://www.healthynewbornnetwork.org/sites/default/files/resources/Hodgins_2015.pdf

AUG

27

New WHO guidance on improving preterm birth outcomes

The WHO recently published new guidance about improving pregnancy outcomes of women at imminent risk of preterm birth, and improving neonatal outcomes of preterm infants soon after birth. The WHO recommendations on interventions to improve preterm birth outcomes are now available and can be accessed at the following link: http://www.who.int/reproductivehealth/publications/maternal_perinatal_health/preterm-birth-guidelines/en/

Tranexamic acid, a drug to reduce bleeding during surgical cases including postpartum bleeding, is potentially suitable for community settings. Using the MANDATE model, we sought to determine the impact of tranexamic acid on PPH-related maternal mortality in sub-Saharan Africa. The analyses point to the importance of preventive and treatment interventions compatible with home and clinic use, especially for sub-Saharan Africa, where the majority of births occur at home or community health clinics. Given its feasibility to be given in the home, tranexamic acid has potential to save many lives.